Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
Hannah Yejin Kim, Evan Ulbricht, Yu Kyung Ahn, Isabelle Sarah Gillooly, Kher Jing Lee, Jessica Lieu, William Nguyen, Sylvia Young, Jin-Gun Cho, Jan-Willem Alffenaar. Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities. Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020

Member's Comments

No comment yet.

Related content which might interest you: Therapeutic drug management: is it the future of multidrug-resistant tuberculosis treatment? Source: Eur Respir J 2013; 42: 1449-1453 Year: 2013 WHO guidelines for the programmatic management of drug-resistant tuberculosis: 2011 update Source: Eur Respir J 2011; 38: 516-528 Year: 2011 Screening and monitoring of tuberculosis in patients on biologics treatment Source: Annual Congress 2012 - Tuberculosis: clinical findings I Year: 2012 Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance Source: International Congress 2018 – Drug-resistant tuberculosis Year: 2018 Rational monitoring of COPD: where do current clinical guidelines stand? Source: Eur Respir J 2007; 29: 1078-1081 Year: 2007 The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 569-571 Year: 2015 The role of therapeutic drug monitoring in individualised drug dosage and exposure measurement in tuberculosis and HIV co-infection Source: Eur Respir J 2015; 45: 571-574 Year: 2015 Monitoring results of diagnostics and treatment of new TB patients in Uliyanovsk region Source: Annual Congress 2010 - Global tuberculosis control Year: 2010 Predicting outcomes and drug resistance with standardised treatment of active tuberculosis Source: Eur Respir J 2010; 36: 870-877 Year: 2010 Impact of continuous medical education (CME) training on improving diagnostic and therapeutic approach to respiratory infections: results of the MATerA project Source: Eur Respir J 2004; 24: Suppl. 48, 86s Year: 2004 Clinical management of COPD: recommended practice including the place of antibiotics Source: Annual Congress 2008 - PG1 - EU GRACE network full-day course: Antibiotics or not: from acute bronchitis to acute exacerbation of chronic bronchitis Year: 2008 Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation Source: Eur Respir J 2014; 44: 1412-1417 Year: 2014 IGRA testing to diagnose TB disease and infection. What is new in clinical practice and for programmatic management Source: School Course 2012 - TB and M/XDR-TB: from clinical management to control and elimination Year: 2012 Enhancing patient safety: New WHO guidance on pharmacovigilance in tuberculosis care Source: Annual Congress 2012 - Tuberculosis: epidemiological and public health features Year: 2012 Rational use of anti-tuberculosis drugs in the EU: better patient care and less drug resistance Source: Eur Respir J 2012; 39: 802-804 Year: 2012 Innovative tools for diagnosis and prevention of paediatric tuberculosis Source: International Congress 2019 – Recent developments and future perspectives in the diagnosis and treatment of tuberculosis Year: 2019 Physician perspectives: monitoring severe AATD and optimising treatment Source: International Congress 2017 – Clinical challenges in chronic lung diseases Year: 2017 Screening and monitoring of TB infection in rheumatological patients on biologics therapy Source: Virtual Congress 2021 – Epidemiological aspects of tuberculosis Year: 2021 Integrating patients with respiratory and cardiac disease in one rehabilitation programme: clinical outcomes of a pragmatic service evaluation. Source: International Congress 2019 – Innovations in care for chronic respiratory conditions Year: 2019 Appreciation efficiency of standard and alternative antituberculosis preventive therapy in children from different tuberculosis infection sources Source: Eur Respir J 2006; 28: Suppl. 50, 28s Year: 2006